Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Equity Ratio: 2010-2024

Historic Equity Ratio for Ani Pharmaceuticals (ANIP) over the last 15 years, with Dec 2024 value amounting to 0.31.

  • Ani Pharmaceuticals' Equity Ratio fell 9.49% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year decrease of 9.49%. This contributed to the annual value of 0.31 for FY2024, which is 44.68% down from last year.
  • Ani Pharmaceuticals' Equity Ratio amounted to 0.31 in FY2024, which was down 44.68% from 0.57 recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Equity Ratio ranged from a high of 0.57 in FY2023 and a low of 0.31 during FY2024.
  • Over the past 3 years, Ani Pharmaceuticals' median Equity Ratio value was 0.53 (recorded in 2022), while the average stood at 0.47.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Equity Ratio climbed by 8.15% in 2021, and later crashed by 44.68% in 2024.
  • Over the past 5 years, Ani Pharmaceuticals' Equity Ratio (Yearly) stood at 0.46 in 2020, then rose by 8.15% to 0.50 in 2021, then increased by 5.72% to 0.53 in 2022, then climbed by 6.97% to 0.57 in 2023, then plummeted by 44.68% to 0.31 in 2024.